Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: Key Findings from a Transformative Quality Improvement Initiative

被引：0
|
作者：
Nawaz, M. Sarfraz [1 ]
Moses-Okwei, Ellie [2 ]
Gurska, Lindsay [2 ]
Zyborowicz, Emily [2 ]
Sullivan, Shelby [2 ]
Carter, Jeffrey [2 ]
Heggen, Cherilyn [2 ]
机构：
[1] Hematol Oncol Indiana, Carmel, IN USA
[2] PRIME Educ, New York, NY USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203606
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7594 / 7595
页数：2
相关论文
共 50 条
  • [31] Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative
    Lai, Catherine
    Bagg, Adam
    Gurska, Lindsay
    Sullivan, Shelby
    Carter, Jeffrey
    Heggen, Cherilyn
    BLOOD, 2023, 142
  • [32] HEALTH-RELATED QUALITY OF LIFE IN DLBCL PATIENTS TREATED WITH CAR T-CELL THERAPY
    Cheng, R.
    Scippa, K.
    Locke, F. L.
    Cole, J.
    Snider, J.
    Jim, H.
    VALUE IN HEALTH, 2021, 24 : S59 - S59
  • [33] T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
    Di Napoli, Raffaella
    Balzano, Nunzia
    Ruggiero, Rosanna
    Mascolo, Annamaria
    Scavone, Cristina
    di Mauro, Gabriella
    Capuano, Annalisa
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [34] Quality of life and CAR T-cell therapy in children, adolescents, and young adults with haematological malignancies
    Efficace, Fabio
    Vignetti, Marco
    LANCET ONCOLOGY, 2019, 20 (12): : 1625 - 1626
  • [35] CAR T-cell therapy landscape in pediatric, adolescent and young adult oncology - A comprehensive analysis of clinical trials
    Martinez-Gamboa, David A.
    Hans, Rhea
    Moreno-Cortes, Eider
    Figueroa-Aguirre, Juana
    Garcia-Robledo, Juan Esteban
    Vargas-Cely, Fabio
    Booth, Natalie
    Castro-Martinez, Daniela A.
    Adams, Roberta H.
    Castro, Januario E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
  • [36] Advancing Treatment and Management of Patients with HR+/HER2-Breast Cancer: Findings from a Quality Improvement Initiative
    Meisel, Jane
    Anderson, Chelsie
    Dewald, Ilona
    Carter, Jeffrey
    Heggen, Cherilyn
    McKinnon, Kelly
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them
    Borogovac, Azra
    Siddiqi, Tanya
    CANCER DRUG RESISTANCE, 2024, 7
  • [38] Biomarker Quality Assurance (QA) Findings From the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) Registry
    Hsi, Eric D.
    Gruver, Aaron M.
    Foss, Francine M.
    Carson, Kenneth R.
    Pinter-Brown, Lauren
    Horwitz, Steven M.
    Rosen, Steven T.
    Pro, Barbara
    Federico, Massimo
    Gisselbrecht, Christian
    BLOOD, 2012, 120 (21)
  • [39] The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy
    1600, Elsevier Ltd (182):
  • [40] Role of Cardio-Oncology Rehabilitation in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Moriyama, Shohei
    Kondo, Moe
    Awamura, Ryuichi
    Hieda, Michinari
    Fukata, Mitsuhiro
    CIRCULATION REPORTS, 2025, 7 (02) : 59 - 65
12345